<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:mp ids='MP_0001794'>Bacterial</z:mp> and <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infections</z:e> are serious complications of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> therapy </plain></SENT>
<SENT sid="1" pm="."><plain>Especially during longstanding <z:hpo ids='HP_0001875'>neutropenia</z:hpo>, patients are at risk for life-threatening <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to assess the effect and safety of G-CSF mobilized granulocyte transfusions (GTX) in four neutropenic pediatric patients with <z:hpo ids='HP_0100806'>sepsis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>PATIENTS AND METHODS: The patients were between 4.6-17.5 years old and their diagnoses included very severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) and <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Before GTX, <z:hpo ids='HP_0000001'>all</z:hpo> patients had <z:hpo ids='HP_0001945'>fever</z:hpo> despite antibiotic and antimycotic therapy, <z:hpo ids='HP_0001875'>neutropenia</z:hpo> (absolute neutrophil count ANC &lt; 500/microl), increasing C-reactive protein (CRP) values, <z:hpo ids='HP_0002615'>hypotension</z:hpo> requiring <z:chebi fb="40" ids="18243">dopamine</z:chebi> infusion and three patients needed supplemental oxygen </plain></SENT>
<SENT sid="5" pm="."><plain>The granulocyte donors received G-CSF (Neupogen, 5 microg/kg body weight) 12 h prior to granulocyte apheresis </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: In total, 40 GTX were performed (range 2-28 per patient) </plain></SENT>
<SENT sid="7" pm="."><plain>The mean increase of the granulocyte count 1 h after GTX was 1,310/microl (range 200-2,950/microl) </plain></SENT>
<SENT sid="8" pm="."><plain>Within the period of GTX the CRP values decreased in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="9" pm="."><plain>During or 24 h after the last GTX, the <z:hpo ids='HP_0002615'>hypotension</z:hpo> resolved and supplemental oxygen was stopped </plain></SENT>
<SENT sid="10" pm="."><plain>One GTX was discontinued because of oxygen desaturation </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: GTX were a safe therapeutic measure with beneficial effects on serious <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> in neutropenic children </plain></SENT>
</text></document>